Constanza Moren
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Increased brain VDAC1 protein levels correlate with behavioural performance in a ketamine murine model of schizophrenia and are attenuated by the mGluR2 modulator JNJ-46356479.
Journal: Schizophrenia research
Published: February 02, 2026
The Potential of Hair Matrix for Biomarker Analysis in Schizophrenia.
Journal: International journal of molecular sciences
Published: August 10, 2025
Bridging theory and practice in schizophrenia care: Nursing models and related psychiatric and psychosocial frameworks.
Journal: Archives of psychiatric nursing
Published: July 11, 2025
Effects of JNJ-46356479 and clozapine on VGLUT1 and GAD65/67 brain levels and expression of genes related to glutamate and GABA in mice postnatally exposed to ketamine.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 04, 2025
Puzzle-based pedagogic activity to address rote learning of antibiotic classes in clinical pharmacology course for undergraduate nursing students.
Journal: BMC medical education
Published: April 23, 2025
Mitochondrial Oxidative Phosphorylation System Dysfunction in Schizophrenia.
Journal: International journal of molecular sciences
Published: April 01, 2025
A grain of sand for schizophrenia: Unmet needs.
Journal: Archives of psychiatric nursing
Published: December 07, 2024
Neuroinflammation: an unfortunate term to describe schizophrenia.
Journal: Molecular psychiatry
Published: December 03, 2024
Effectiveness of positive allosteric modulators of metabotropic glutamate receptor 2/3 (mGluR2/3) in animal models of schizophrenia.
Journal: Translational psychiatry
Published: December 22, 2023
Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophrenia.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: October 09, 2023
Last Updated: 09/26/2026